EFFECT OF 1,25-DIHYDROXYCHOLECALCIFEROL, CHOLECALCIFEROL, AND FLUORESCENT LIGHTS ON THE DEVELOPMENT OF TIBIAL DYSCHONDROPLASIA AND RICKETS IN BROILER-CHICKENS
Ma. Elliot et Hm. Edwards, EFFECT OF 1,25-DIHYDROXYCHOLECALCIFEROL, CHOLECALCIFEROL, AND FLUORESCENT LIGHTS ON THE DEVELOPMENT OF TIBIAL DYSCHONDROPLASIA AND RICKETS IN BROILER-CHICKENS, Poultry science, 76(4), 1997, pp. 570-580
Experiments were conducted to determine whether dietary 1,25-dihydroxy
cholecalciferol [1,25-(OH)(2)D-2] will alleviate a cholecalciferol def
iciency induced by low dietary cholecalciferol and no fluorescent ligh
ting and to determine cholecalciferol requirements as influenced by fl
uorescent lighting or 1,25-(OH)(2)D-3. In each study, nutritionally co
mplete basal diets were fed to broiler cockerels from 1 to 16 d of age
. Experiment 1 had a 2 x 2 x 2 factorial arrangement of treatments wit
h 1,25-(OH)(2)D-3 at 0 and 10 mu g/kg, cholecalciferol at 2.75 and 27.
5 mu g/kg, and fluorescent lights on or off. Experiments 2 to 4 had fo
ur levels of dietary cholecalciferol (0, 5.0, 27.5, and 50.0 mu g/kg)
and fluorescent lights on or off (Experiment 2) or 1,25-(OH)(2)D-3 at
0 and 10 mu g/kg (Experiments 3 and 4). In Experiment 1, fluorescent l
ighting increased bone ash, and decreased the incidence and severity o
f rickets at 2.75 mu g/kg cholecalciferol and 0 mu g/kg 1,25-(OH)(2)D-
3 and reduced the severity of TD at both levels of cholecalciferol and
0 mu g/kg 1,25-(OH)(2)D-3. In all cases 1,25-(OH)(2)D-3 improved bone
ash. The metabolite also decreased the incidence ans severity of TD a
t both cholecalciferol levels with lights off and decreased the incide
nce and severity of rickets at 2.75 mu g/kg cholecalciferol and lights
off. In the absence of fluorescent lighting and 1,25-(OH)(2)D-3 27.5
mu g/kg cholecalciferol reduced the incidence and severity of rickets
to levels equivalent to those produced by eith fluorescent lighting or
1,25-(OH)(2)D-3 alone (Experiments 2,3, and 4). However, even 50.0 mu
g/kg cholecalciferol was not as effective as fluorescent lights or 1,
25-(OH)(2)D-3 in reducing the incidence and severity of TD.